The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD. 2018-06-22 - NIH; National Institute of Health; U.S. National Library of Medicine – ClinicalTrials.gov (2018)
Stand: